Low correspondence between K-ras mutations in pancreatic cancer tissue and detection of K-ras mutations in circulating DNA.
about
Circulating Tumor Cells and Circulating Tumor DNA Provide New Insights into Pancreatic CancerAnalysis of microRNAs in pancreatic fine-needle aspirates can classify benign and malignant tissues.Hedgehog signaling antagonist GDC-0449 (Vismodegib) inhibits pancreatic cancer stem cell characteristics: molecular mechanisms.GANT-61 inhibits pancreatic cancer stem cell growth in vitro and in NOD/SCID/IL2R gamma null mice xenograftDiagnostic value of microRNA for pancreatic cancer: a meta-analysis.Diagnostic value of combining CA 19-9 and K-ras gene mutation in pancreatic carcinoma: a meta-analysis.K-ras mutation and p16 and preproenkephalin promoter hypermethylation in plasma DNA of pancreatic cancer patients: in relation to cigarette smoking.Pharmacodynamic separation of gemcitabine and erlotinib in locally advanced or metastatic pancreatic cancer: therapeutic and biomarker resultsQuantitative assessment of the diagnostic role of human telomerase activity from pancreatic juice in pancreatic cancer.Circulating free DNA as biomarker and source for mutation detection in metastatic colorectal cancerThe receptor for advanced glycation end products (RAGE) enhances autophagy and neutrophil extracellular traps in pancreatic cancer.Emerging molecular biomarkers--blood-based strategies to detect and monitor cancer.Possible role of autophagy in the treatment of pancreatic cancer with histone deacetylase inhibitors.K-RAS mutation in the screening, prognosis and treatment of cancer.Clinical relevance of circulating KRAS mutated DNA in plasma from patients with advanced pancreatic cancer.Early changes in plasma DNA levels of mutant KRAS as a sensitive marker of response to chemotherapy in pancreatic cancer.Snail transcript levels in diagnosis of pancreatic carcinoma with fine-needle aspirate.GANT-61 and GDC-0449 induce apoptosis of prostate cancer stem cells through a GLI-dependent mechanism.Clinical validity of detecting K-ras mutations for the diagnosis of exocrine pancreatic cancer: a prospective study in a clinically-relevant spectrum of patients.
P2860
Q28073765-301EE3C7-91FE-4BE1-B5EF-BEC6B458117EQ33693132-78472D47-909E-4BF2-B5B5-93A923055B39Q34075584-9300838F-2F1A-45E9-B188-165BB3E5E817Q34129830-7831705F-182F-4045-B22B-DE9093D8F242Q34489537-A24E84A2-3E8B-4B84-B520-140B833B395CQ34547888-4D9FC49D-ABED-4EAB-BE60-C318C25249B9Q34596601-C442CC98-86A2-4EC9-AA02-6327A0860B39Q35054633-51F201B8-5D51-4006-89FC-A3F22EBAF8C6Q35168533-EF1FE0FC-3BF0-4FE5-9027-F824569ED1B8Q35392062-05096C77-34FA-4237-9933-8333F02F60D5Q35752134-295279DD-1B42-4F37-8AAC-CC72E27B758CQ37848663-7A88F3BA-92B6-47E8-989C-EE28DAD089B5Q38166587-91BF71F9-3C27-42B7-BACB-BFCCE5B11C5FQ39872545-0E481367-E13C-4FB9-83B4-6BA419FE9AAAQ40149888-27361FC4-B539-43E4-B70D-457D92EB67D9Q40495250-F87E00AD-8826-47EC-B100-AC346A5DCBC4Q41175510-B4C5AEDD-CD5A-4B60-84AB-4BC8CB278518Q47258214-8C321118-E016-492D-9071-C2E0FADC5014Q54389082-719F7BDC-E962-4A5B-B8B2-9CA2A9D7E260
P2860
Low correspondence between K-ras mutations in pancreatic cancer tissue and detection of K-ras mutations in circulating DNA.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Low correspondence between K-r ...... mutations in circulating DNA.
@en
Low correspondence between K-r ...... mutations in circulating DNA.
@nl
type
label
Low correspondence between K-r ...... mutations in circulating DNA.
@en
Low correspondence between K-r ...... mutations in circulating DNA.
@nl
prefLabel
Low correspondence between K-r ...... mutations in circulating DNA.
@en
Low correspondence between K-r ...... mutations in circulating DNA.
@nl
P2093
P1433
P1476
Low correspondence between K-r ...... s mutations in circulating DNA
@en
P2093
Adriano Tocchi
Alessandra Muleti
Antonio Stigliano
Barbara Bucci
Ercole Brunetti
Gianluca Mazzoni
Monica De Angelis
Rodolfo Marchese
P304
P356
10.1097/01.MPA.0000202938.63084.E3
P577
2006-03-01T00:00:00Z